Autolus Therapeutics plc Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Autolus Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Autolus Therapeutics plc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$14.2M, a 379% decline year-over-year.
  • Autolus Therapeutics plc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$51.4M, a 9120% decline year-over-year.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2023 was -$28.7M, a 456% decline from 2022.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2022 was -$5.16M, a 422% decline from 2021.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2021 was -$988K, a 152% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.